DePuy Synthes was created in 2012 after Johnson & Johnson paid $21.3 billion for the medical device manufacturer with offices in West Chester, Pa., and Switzerland. It specializes in spine and bone repair products.
Johnson & Johnson said the 400 positions being eliminated in the restructuring represents less than 2 percent of the company’s 23,000-person workforce. A spokesman told the Wall Street Journal that more than 80 new positions have been created at DePuy Synthes as part of the reorganization.
Lorie Gaweluk, a spokeswoman for DePuy Synthes, said the roles of a majority of the company’s employees “won’t change or will change minimally.” Gaweluk said jobs being eliminated, added or changed will occur “across many sites and areas” of the business. She said she could not, at this time, provide specific information on jobs cuts or employee numbers at West Chester or any other site.
John George covers health care, biotech/pharmaceuticals and sports business.